Master's Course "Drug Regulatory Affairs"

Study Modules

Modul 11 (WS 2017 / SS 2018)

Pharmacoeconomics / Health policy

attendance approx. Seminar Paper Method of examination Credit
approx. 20 h approx. 20 h seminar paper 3

Module Supervisor

  • Dr. Dr. Karl J. Krobot, Haar


1   General principles
  • Healthcare policy situation in Germany
  Reimbursement of drug costs
  • Introduction to and general principles of social law
  • Principles of the statutory health insurance system
  • The performance law of the statutory health insurance system
  • Control instruments of the statutory health insurance system for pharmaceutical supply
  • Laws pertaining to doctors within the statutory health insurance system
  • Review of the cost efficiency of treatment and prescribing practices in the statutory health insurance system
  • New provision channels in the statutory health insurance system
  • The drug budget and reference size review for drugs in statutory health insurance system
3   Methods for the comparative evaluation of pharmaceutical products
  • An international stock-taking in the field of drug evaluation

Drug benefit evaluation and healthcare provision research

  • Principles of the drug benefit evaluation
  • Benefit assessment by the Institute for Quality and Cost Efficiency in the Healthcare System (IQWIG)
  • The quality-adjusted year of life
  • Cost per quality-adjusted year of life
  • Healthcare provision research: definition and value
  • Principles
  • National and international sample cases



Drug evaluation by the IQWiG

Study plan

Thursday   05 July 2018 from 2.00 p.m. – 6.45 p.m.
Friday   06 July 2018 from 8.30 a.m. – 6.30 p.m.
Saturday   07 July 2018 from 8.00 a.m. – 4.00 p.m.
Location:   Uni-Club
    Deadline seminar paper: 06 August 2018

DocumentationOnly for members

Please login to your account.